Randomized double-blind placebo-controlled crossover study of caffeine in patients with intermittent claudication

British Journal of Surgery

Volumn 97, Issue 10, 2010, Pages 1503-1510

  Momsen, A H ^a   Jensen, M B ^b   Norager, C B ^a   Madsen, M R ^a   Vestersgaard Andersen, T ^c   Lindholt, J S ^c  

^a HERNING HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Surgical Research Units   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CENTRAL STIMULANT AGENT;

AGED; ARTICLE; BLOOD PRESSURE; BODY POSTURE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDURANCE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MALE; MULTICENTER STUDY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PAIN; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; WALKING;

AGED; BLOOD PRESSURE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; ISOMETRIC CONTRACTION; MALE; MUSCLE STRENGTH; PAIN; PHYSICAL ENDURANCE; POSTURE; REACTION TIME; WALKING;

EID: 77957012354     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7149     Document Type: Article

References (27)

1. de Backer TL, Bogaert M, Vander Stichelle R. Buflomedil for intermittent claudication. Cochrane Database Syst Rev 2008; (1)CD000988.
2. de Backer TL, Vander Stichelle R, Lehert P, Van Bortel L. Naftidrofuryl for intermittent claudication. Cochrane Database Syst Rev 2008; (2)CD001368.
3. Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev 2007; (4)CD000123.
4. Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen TB, Lindholt JS. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomized controlled studies. Eur J Vasc Endovasc Surg 2009; 38: 463-474.
5. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009; 301: 165-174.
6. Wang J, Zhou S, Bronks R, Graham J, Myers S. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease. Clin Rehabil 2007; 21: 579-586.
7. Graham TE. Caffeine and exercise: metabolism, endurance and performance. Sports Med 2001; 31: 785-807.
8. Falk B, Burstein R, Ashkenazi I, Spilberg O, Alter J, Zylber-Katz E et al. The effect of caffeine ingestion on physical performance after prolonged exercise. Eur J Appl Physiol Occup Physiol 1989; 59: 168-173.
9. Norager CB, Jensen MB, Weimann A, Madsen MR. Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study. Clin Endocrinol (Oxf) 2006; 65: 223-228.
10. Berglund B, Eklund B. Reproducibility of treadmill exercise in patients with intermittent claudication. Clin Physiol 1981; 1: 253-256.
11. Peräkylä T, TikkanenH, von Knorring J, Lepäntalo M. Poor reproducibility of exercise test in assessment of claudication. Clin Physiol 1998; 18: 187-193.
12. Altstaedt HO, Berzewski B, Breddin HK, BrockhausW, Bruhn HD, Cachovan M et al. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 573-578.
13. McDermott MM, Greenland P, Liu K, Guralnik JM, Celic L, Criqui MH et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med 2002; 136: 873-883.
14. Rantanen T, Era P, Heikkinen E. Physical activity and the changes in maximal isometric strength in men and women from the age of 75-80 years. J AmGeriatr Soc 1997; 45: 1439-1445. (Pubitemid 127747112)
15. Spreen O, Benton AL. Comparative studies of some psychological tests for cerebral damage. J Nerv Ment Dis 1965; 140: 323-333.
16. Norgren L, HiattWR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(Suppl S): S5-S67. (Pubitemid 46151680)
17. Zwierska I, Nawaz S,Walker RD, Wood RF, Pockley AG, Saxton JM. Treadmill versus shuttle walk tests of walking ability in intermittent claudication. Med Sci Sports Exerc 2004; 36: 1835-1840.
18. Hood SC, Moher D, Barber GG. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials. CMAJ 1996; 155: 1053-1059.
19. Walker GA, Mac Hannaford JC. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication. Fundam Clin Pharmacol 1995; 9: 387-394.
20. Müller-Bühl U, Kirchberger I, Wiesemann A. Relevance of claudication pain distance in patients with peripheral arterial occlusive disease. Vasa 1999; 28: 25-29.
21. Norager CB, Jensen MB, Madsen MR, Laurberg S. Caffeine improves endurance in 75-yr-old citizens: a randomized, double-blind, placebo-controlled, crossover study. J Appl Physiol 2005; 99: 2302-2306.
22. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-1324.
23. Franks HM, Hagedorn H, Hensley VR, Hensley WJ, Starmer GA. The effect of caffeine on human performance, alone and in combination with ethanol. Psychopharmacologia 1975; 45: 177-181.
24. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992; 17: 139-170.
25. Anselme F, Collomp K, Mercier B, Ahmaïdi S, Prefaut C. Caffeine increases maximal anaerobic power and blood lactate concentration. Eur J Appl Physiol Occup Physiol 1992; 65: 188-191.
26. Van Soeren MH, Graham TE. Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawal. J Appl Physiol 1998; 85: 1493-1501.
27. Graham TE, Battram DS, Dela F, El-Sohemy A, Thong FS. Does caffeine alter muscle carbohydrate and fat metabolism during exercise? Appl Physiol Nutr Metab 2008; 33: 1311-1318.